昭衍新药(06127)监事拟合计减持不超3.4万股

智通财经2022-06-13

智通财经APP讯，昭衍新药(06127)发布北京昭衍新药研究中心股份有限公司监事集中竞价减持股份计划公告。监事孙辉业、尹丽莉、李叶拟自本减持计划公告之日起15个交易日后(即7月5日起)的6个月内，通过上海证券交易所集中竞价的交易方式分别减持不超过1万股、1.1万股、1.3万股，合计减持不超过3.4万股，不超过公司当前总股本的0.01%。减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2243351956?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2022-06-13 16:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2243351956","market":"sh","top_or_hot":-1,"title":"昭衍新药(06127)监事拟合计减持不超3.4万股","media":"智通财经","content":"<div>\n<p>智通财经APP讯，昭衍新药(06127)发布北京昭衍新药研究中心股份有限公司监事集中竞价减持股份计划公告。监事孙辉业、尹丽莉、李叶拟自本减持计划公告之日起15个交易日后(即7月5日起)的6个月内，通过上海证券交易所集中竞价的交易方式分别减持不超过1万股、1.1万股、1.3万股，合计减持不超过3.4万股，不超过公司当前总股本的0.01%。减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/737746.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昭衍新药(06127)监事拟合计减持不超3.4万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昭衍新药(06127)监事拟合计减持不超3.4万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-13 16:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/737746.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，昭衍新药(06127)发布北京昭衍新药研究中心股份有限公司监事集中竞价减持股份计划公告。监事孙辉业、尹丽莉、李叶拟自本减持计划公告之日起15个交易日后(即7月5日起)的6个月内，通过上海证券交易所集中竞价的交易方式分别减持不超过1万股、1.1万股、1.3万股，合计减持不超过3.4万股，不超过公司当前总股本的0.01%。减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/737746.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603127","symbol_name":"昭衍新药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/737746.html","article_id":"2243351956","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2243351956","pubTimestamp":1655110478,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，昭衍新药(06127)发布北京昭衍新药研究中心股份有限公司监事集中竞价减持股份计划公告。监事孙辉业、尹丽莉、李叶拟自本减持计划公告之日起15个交易日后(即7月5日起)的6个月内，通过上海证券交易所集中竞价的交易方式分别减持不超过1万股、1.1万股、1.3万股，合计减持不超过3.4万股，不超过公司当前总股本的0.01%。减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发新股或配股等股本除权、除息事项的，减持数量将进行相应调整。减持价格依据市场价格确定。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603127":"昭衍新药","06127":"昭衍新药","BK1141":"生命科学工具和服务","BK1576":"医药外包概念"},"translate_title":"The supervisor of Zhaoyan New Drug (06127) plans to reduce his total holdings by no more than 34,000 shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603127":1,"06127":1},"content_text":"智通财经APP讯，昭衍新药(06127)发布北京昭衍新药研究中心股份有限公司监事集中竞价减持股份计划公告。监事孙辉业、尹丽莉、李叶拟自本减持计划公告之日起15个交易日后(即7月5日起)的6个月内，通过上海证券交易所集中竞价的交易方式分别减持不超过1万股、1.1万股、1.3万股，合计减持不超过3.4万股，不超过公司当前总股本的0.01%。减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发新股或配股等股本除权、除息事项的，减持数量将进行相应调整。减持价格依据市场价格确定。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2243351956"}